Serina Therapeutics, Inc. (SER) Financials

SER Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 25.8 million 7.1 million
March 31, 2026 27.3 million 9.7 million
Dec. 31, 2025 7.0 million 7.0 million
Sept. 30, 2025 12.4 million 10.8 million

SER Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.7 million 1.1 million
March 31, 2026 -4.6 million 1.1 million
Dec. 31, 2025 -6.0 million 948000
Sept. 30, 2025 -3.9 million 999000

SER Net Income

No data available :(

SER Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 23.0 million 122000 122000
March 31, 2026 24.5 million 3.0 million 159000
Dec. 31, 2025 4.8 million 2.9 million 196000
Sept. 30, 2025 8.6 million - 148000

SER Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 16.4 million
March 31, 2026 12.0 million
Dec. 31, 2025 10.2 million
Sept. 30, 2025 10.3 million

SER Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 28000 3.8 million 3.0 million -
March 31, 2026 25000 3.2 million 3.1 million -
Dec. 31, 2025 59000 3.4 million 2.8 million 203000
Sept. 30, 2025 13000 3.7 million 2.7 million -

SER Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 18000
Dec. 31, 2025 - 3.4 million
Sept. 30, 2025 - 3.7 million

SER Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SER

Price: $1.66

52 week price:
1.22
5.83

Earnings Per Share: -1.87 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 29.4 million

Links: